Neoplasm, Residual

"Neoplasm, Residual" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Remnant of a tumor or cancer after primary, potentially curative therapy.

Descriptor ID	D018365
MeSH Number(s)	C04.697.700 C23.550.727.700
Concept/Terms	Neoplasm, Residual Neoplasm, Residual Residual Neoplasms Residual Neoplasm Minimal Residual Disease Minimal Disease, Residual Residual Minimal Disease Residual Minimal Diseases Residual Disease, Minimal Minimal Residual Diseases Residual Cancer Residual Cancer Cancer, Residual Residual Cancers Residual Tumor Residual Tumor Residual Tumors Residual Tumour Residual Tumours Tumour, Residual

Below are MeSH descriptors whose meaning is more general than "Neoplasm, Residual".

Diseases [C]
Neoplasms [C04]
Neoplastic Processes [C04.697]
Neoplasm, Residual [C04.697.700]
Pathological Conditions, Signs and Symptoms [C23]
Pathologic Processes [C23.550]
Neoplastic Processes [C23.550.727]
Neoplasm, Residual [C23.550.727.700]

Below are MeSH descriptors whose meaning is related to "Neoplasm, Residual".

Below are MeSH descriptors whose meaning is more specific than "Neoplasm, Residual".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Neoplasm, Residual" by people in this website by year, and whether "Neoplasm, Residual" was a major or minor topic of these publications.

Bar chart showing 51 publications over 20 distinct years, with a maximum of 6 publications in 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	0	1	1
2002	1	1	2
2003	0	1	1
2004	0	3	3
2005	1	2	3
2007	0	1	1
2008	0	3	3
2009	0	2	2
2010	2	1	3
2011	0	2	2
2012	0	1	1
2013	0	4	4
2014	1	3	4
2015	0	2	2
2016	1	3	4
2017	0	1	1
2018	2	1	3
2020	1	5	6
2021	0	2	2
2022	0	3	3

Below are the most recent publications written about "Neoplasm, Residual" by people in Profiles.

O'Cearbhaill RE, P?rez-Fidalgo JA, Monk BJ, Tusquets I, McCormick C, Fuentes J, Moore RG, Vulsteke C, Shahin MS, Forget F, Bradley WH, Hietanen S, O'Malley DM, D?rum A, Slomovitz BM, Baumann K, Selle F, Calvert PM, Artioli G, Levy T, Kumar A, Malinowska IA, Li Y, Gupta D, Gonz?lez-Mart?n A. Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study. Gynecol Oncol. 2022 07; 166(1):36-43.

View in: PubMed
Arisi MF, Dotan E, Fernandez SV. Circulating Tumor DNA in Precision Oncology and Its Applications in Colorectal Cancer. Int J Mol Sci. 2022 Apr 18; 23(8).

View in: PubMed
LaFargue CJ, Handley KF, Fleming ND, Nick AM, Chelariu-Raicu A, Fellman B, Castellano T, Ogasawara A, Hom-Tedla M, Blake EA, da Costa AABA, Crim AK, Rauh-Hain A, Westin SN, Coleman RL, Matsuo K, Baiocchi G, Hasegawa K, Moore K, Sood AK. Clinical analysis of pathologic complete responders in advanced-stage ovarian cancer. Gynecol Oncol. 2022 04; 165(1):82-89.

View in: PubMed
Siedlecki J, Pulido J, Priglinger S. Minimal Residual Disease in Neovascular Age-Related Macular Degeneration. Klin Monbl Augenheilkd. 2021 Jun; 238(6):700-702.

View in: PubMed
Lanahan CR, Kelly BN, Gadd MA, Specht MC, Brown CL, Hughes KS, Tang R, Rai U, Brachtel EF, Rice-Stitt T, Smith BL. Performance of a novel protease-activated fluorescent imaging system for intraoperative detection of residual breast cancer during breast conserving surgery. Breast Cancer Res Treat. 2021 May; 187(1):145-153.

View in: PubMed
Germans SK, Kulak O, Koduru P, Oliver D, Gagan J, Patel P, Anderson LD, Fuda FS, Chen W, Jaso JM. Lenalidomide-Associated Secondary B-Lymphoblastic Leukemia/Lymphoma-A Unique Entity. Am J Clin Pathol. 2020 11 04; 154(6):816-827.

View in: PubMed
Quagliano A, Gopalakrishnapillai A, Kolb EA, Barwe SP. CD81 knockout promotes chemosensitivity and disrupts in vivo homing and engraftment in acute lymphoblastic leukemia. Blood Adv. 2020 09 22; 4(18):4393-4405.

View in: PubMed
Dunavoelgyi R, Milman T, Shields CL, Schmidt-Erfurth U, Pulido JS. Minimal residual disease-a novel concept in uveal melanoma. Eye (Lond). 2021 03; 35(3):702-704.

View in: PubMed
Stacey AW, Pulido JS. The Concept of Minimal Residual Disease in the Treatment and Staging of Vitreoretinal Lymphoma. Retina. 2020 Jul; 40(7):1213-1214.

View in: PubMed
Crowgey EL, Mahajan N, Wong WH, Gopalakrishnapillai A, Barwe SP, Kolb EA, Druley TE. Error-corrected sequencing strategies enable comprehensive detection of leukemic mutations relevant for diagnosis and minimal residual disease monitoring. BMC Med Genomics. 2020 03 04; 13(1):32.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement